Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash from Financing Activities of -$144.0 million for Q2 2026, down 24.14% year-over-year from -$189.8 million in Q2 2025, and up 35.14% quarter-over-quarter from -$222.0 million in Q1 2026.
Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Cash from Financing Activities for 18 consecutive years, with -$144.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 24.14% year-over-year to -$144.0 million; the TTM figure through Apr 2026 stood at -$785.0 million (down 51.84% YoY), while the FY2025 annual figure was -$715.0 million, up 4.92% from the prior year.
- Cash from Financing Activities climbed to -$144.0 million in Q2 2026 per A's latest filing, from -$222.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $25.0 million in Q4 2024 and bottomed at -$546.0 million in Q1 2022.
- Historically, Cash from Financing Activities has averaged -$229.7 million across 5 years, with a median of -$220.5 million in 2025.
- On a YoY basis, Cash from Financing Activities climbed as much as 112.44% in 2024 and fell as far as 1311.76% in 2024.
- Agilent Technologies' Cash from Financing Activities stood at -$341.0 million in 2022, then surged by 41.06% to -$201.0 million in 2023, then jumped by 112.44% to $25.0 million in 2024, then plunged by 900.0% to -$200.0 million in 2025, then grew by 28.0% to -$144.0 million in 2026.
- Business Quant data shows A's Cash from Financing Activities at -$144.0 million in Q2 2026, -$222.0 million in Q1 2026, and -$200.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | -229.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -144.00 Mn |
| Apr 30, 2026 | -144.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Jan 31, 2024 | -240.00 Mn |
| Jan 31, 2024 | -240.00 Mn |